These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29563674)

  • 21. An analysis of blood utilization for elective surgery in a tertiary medical centre in Malaysia.
    Jayaranee S; Prathiba R; Vasanthi N; Lopez CG
    Malays J Pathol; 2002 Jun; 24(1):59-66. PubMed ID: 16329557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How rational is the crossmatching of blood in a pediatric emergency department?
    Grupp-Phelan J; Tanz RR
    Arch Pediatr Adolesc Med; 1996 Nov; 150(11):1140-4. PubMed ID: 8904853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of donor blood wastage due to outdating in a large teaching hospital.
    Feng CS; Ng AK
    Pathology; 1991 Jul; 23(3):195-7. PubMed ID: 1780186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion.
    Odunayo A; Garraway K; Rohrbach BW; Rainey A; Stokes J
    J Am Vet Med Assoc; 2017 Feb; 250(3):303-308. PubMed ID: 28117642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-i causing acute hemolysis following a negative immediate-spin crossmatch.
    Judd WJ; Steiner EA; Abruzzo LV; Davenport RD; Oberman HA; Pehta JC; Nance SJ
    Transfusion; 1992; 32(6):572-5. PubMed ID: 1502712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
    Pinkerton PH; Coovadia AS; Goldstein J
    Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electronic verification of donor-recipient compatibility: the computer crossmatch.
    Butch SH; Judd WJ; Steiner EA; Stoe M; Oberman HA
    Transfusion; 1994 Feb; 34(2):105-9. PubMed ID: 8310478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with a cost-effective crossmatch protocol.
    Shulman IA; Nelson JM; Kent DR; Jacobs VL; Nakayama RK; Malone SA
    JAMA; 1985 Jul; 254(1):93-5. PubMed ID: 3999355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal hemolytic transfusion reaction resulting from ABO mistyping of a patient with acquired B antigen detectable only by some monoclonal anti-B reagents.
    Garratty G; Arndt P; Co A; Rodberg K; Furmanski M
    Transfusion; 1996 Apr; 36(4):351-7. PubMed ID: 8623139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India.
    Pathak S; Chandrashekhar M; Wankhede GR
    Asian J Transfus Sci; 2011 Jul; 5(2):153-6. PubMed ID: 21897595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization.
    Benson K; Agosti SJ; Latoni-Benedetti GE; Leparc GF
    Transfusion; 2003 Jun; 43(6):753-7. PubMed ID: 12757526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric crossmatch for kidney transplantation.
    Koktathong K; Vejbaesya S; Bejrachandra S; Pattanapanyasat K
    J Med Assoc Thai; 2005 Jun; 88(6):769-74. PubMed ID: 16083217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting.
    Chaudhary R; Agarwal N
    Asian J Transfus Sci; 2011 Jul; 5(2):157-9. PubMed ID: 21897596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety.
    Kuriyan M; Fox E
    Vox Sang; 2000; 78(2):113-8. PubMed ID: 10765147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in the use of type and crossmatch blood ordering among patients undergoing hepatic and pancreatic resections.
    Ejaz A; Frank SM; Spolverato G; Mavros M; Kim Y; Pawlik TM
    Surgery; 2016 Mar; 159(3):908-18. PubMed ID: 26384235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS.
    Ndahimana E; Gothot A; Gérard C; Senyana F; R'Zik S; Mukabayire O; Mutesa L
    East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type and screen: a safe and effective preoperative blood ordering policy with emphasis on its use in obstetrics and gynecology.
    Patten E; Alperin JB
    Am J Obstet Gynecol; 1982 Mar; 142(5):563-7. PubMed ID: 7058860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed hemolytic transfusion reaction due to anti-Jk(a).
    Vucelic D; Savic N; Djordjevic R
    Acta Chir Iugosl; 2005; 52(3):111-5. PubMed ID: 16813007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusion significance of Lewis system antibodies. Success in transfusion with crossmatch-compatible blood.
    Waheed A; Kennedy MS; Gerhan S; Senhauser DA
    Am J Clin Pathol; 1981 Sep; 76(3):294-8. PubMed ID: 7282630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.